telmisartan has been researched along with Respiratory Tract Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; DiCostanzo, JR; Donini, O; Lee, D; Lehrer, AT; Shikuma, CM; Shimoda, L; Suk, JS; Thompson, K; Yun, X | 1 |
1 other study(ies) available for telmisartan and Respiratory Tract Infections
| Article | Year |
|---|---|
Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory Infections.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; COVID-19; Renin-Angiotensin System; Respiratory Tract Infections; SARS-CoV-2; Telmisartan | 2023 |